Search For "ram vishwakarma"
Updated : 1 year, 1 month ago IST
Chandigarh (Punjab) [India], April 29 (ANI): The clinical trial to position immunomodulator Sepsivac as a drug has begun at PGIMER Chandigarh, said Dr. Ram Vishwakarma, coordinator of the trial program for the use of Sepsivac in COVID-19 treatment.
Updated : 1 year, 2 months ago IST
Jammu (Jammu and Kashmir) [India], April 8 (ANI): The Council of Scientific and Industrial Research (CSIR) and Indian Institute of Integrative Medicine (IIIM) are working together for testing COVID-19 samples.